STAT3 and cancer: Studies have shown that STAT3 is transiently activated in normal tissues to maintain normal cell biological functions, while its activation is continuous in CAFs and cancer cells (Avalle et al., 2022; Johnson et al., 2018; Li H. et al., 2022; Yu et al., 2014).